U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 396

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh38:
Chr16:46385317-61223349
NLRC5, NOD2, NUDT21, NUP93, POLR2C, PRSS54, PSME3IP1, NUP93-DT, ORC6, PHKB, RBL2, RPGRIP1L, RSPRY1, SALL1, OGFOD1, PLLP, MIR6771, MIR6772, MIR6863, MMP15, MMP2, MMP2-AS1, MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, MT2A, MT3, MT4, MYLK3, N4BP1, NDRG4, NETO2, NKD1, SETD6, SHCBP1, SIAH1, SLC12A3, SLC38A7, SLC6A2, SNORA46, SNORA50A, SNORD148, SNX20, TENT4B, TEPP, TOX3, TRL-CAG2-1, TRL-CAG2-2, USB1, VPS35, ZNF319, ZNF423, ABCC11, ABCC12, ADCY7, ADGRG1, ADGRG3, ADGRG5, AKTIP, AMFR, ARL2BP, BBS2, BRD7, C16orf78, C16orf87, CAPNS2, CASC16, CASC22, CBLN1, CCDC102A, CCDC113, CCL17, CCL22, CES1, CES5A, CETP, CFAP20, CHD9, CHD9NB, CIAPIN1, CNEP1R1, CNGB1, CNOT1, COQ9, CPNE2, CRNDE, CSNK2A2, CX3CL1, CYLD, CYLD-AS1, DNAJA2, DOK4, DRC7, FTO, FTO-IT1, GINS3, GNAO1, GNAO1-AS1, GNAO1-DT, GOT2, GPT2, HEATR3, HERPUD1, HNRNPA1L3, IRX3, IRX5, IRX6, ITFG1, ITFG1-AS1, KATNB1, KIFC3, LINC00919, LINC01571, LINC02127, LINC02128, LINC02133, LINC02134, LINC02137, LINC02140, LINC02141, LINC02168, LINC02169, LINC02178, LINC02179, LINC02180, LINC02192, LINC02911, LINC03064, LOC100507577, LOC101927272, LOC101927480, LOC102723373, LOC110120574, LOC110120575, LOC110120576, LOC110120577, LOC110120578, LOC110120579, LOC110120580, LOC110120581, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120823, LOC110120826, LOC110120835, LOC110120836, LOC110120837, LOC110120838, LOC110120839, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC110121339, LOC110121356, LOC112449709, LOC112449712, LOC112449713, LOC112449714, LOC112449715, LOC112449716, LOC112449717, LOC112469003, LOC112469004, LOC112469005, LOC112469006, LOC112469007, LOC112469008, LOC112469009, LOC112469010, LOC112469011, LOC112469012, LOC112469013, LOC112469014, LOC113939952, LOC113939953, LOC113939954, LOC121587544, LOC121587545, LOC121587546, LOC121587547, LOC121587548, LOC121847987, LOC121847988, LOC121847989, LOC125146444, LOC125177302, LOC125177304, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC125177311, LOC125177312, LOC125177313, LOC125177314, LOC125177315, LOC125177316, LOC125177317, LOC125177318, LOC125177319, LOC125177320, LOC125177322, LOC125177323, LOC125177324, LOC125177325, LOC125177326, LOC125177327, LOC125177328, LOC126862336, LOC126862337, LOC126862338, LOC126862339, LOC126862340, LOC126862341, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, LOC126862355, LOC126862356, LOC126862357, LOC126862358, LOC126862359, LOC126862360, LOC126862361, LOC126862362, LOC126862363, LOC126862364, LOC388282, LONP2, LPCAT2, MIR138-2, MIR3181, MIR3935
not providedPathogenic
(Jul 17, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr16:46500741-52456082
GRCh38:
Chr16:46466829-52422170
See casesPathogenic
(Apr 8, 2011)
no assertion criteria provided
3.
GRCh37:
Chr16:46500741-52389705
GRCh38:
Chr16:46466829-52355793
See casesPathogenic
(Dec 22, 2010)
no assertion criteria provided
4.
GRCh37:
Chr16:46500741-51707107
GRCh38:
Chr16:46466829-51673196
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
5.
GRCh37:
Chr16:46500741-51973216
GRCh38:
Chr16:46466829-51939304
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
6.
GRCh37:
Chr16:46505432-52439868
GRCh38:
Chr16:46471520-52405956
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
7.
GRCh37:
Chr16:47284555-54155388
GRCh38:
Chr16:47250644-54121476
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
8.
GRCh37:
Chr16:48576994-53913828
GRCh38:
Chr16:48543083-53879916
Ductal breast carcinomaUncertain significance
(Jul 20, 2015)
no assertion criteria provided
9.
GRCh37:
Chr16:49604464-53500977
GRCh38:
Chr16:49570553-53467065
See casesPathogenic
(Aug 29, 2011)
no assertion criteria provided
10.
GRCh37:
Chr16:49719432-68435615
GRCh38:
Chr16:49685521-68401712
ACD, ADCY7, ADGRG1, ADGRG3, ADGRG5, AGRP, AKTIP, AMFR, ARL2BP, ATP6V0D1, ATP6V0D1-DT, B3GNT9, BBS2, BEAN1, BEAN1-AS1, BRD7, C16orf86, CA7, CAPNS2, CARMIL2, CASC16, CASC22, CBFB, CCDC102A, CCDC113, CCL17, CCL22, CDH11, CDH16, CDH5, CDH8, CENPT, CES1, CES2, CES3, CES4A, CES5A, CETP, CFAP20, CHD9, CHD9NB, CIAO2B, CIAPIN1, CKLF, CKLF-CMTM1, CMTM1, CMTM2, CMTM3, CMTM4, CNEP1R1, CNGB1, CNOT1, COQ9, CPNE2, CRNDE, CSNK2A2, CTCF, CTCF-DT, CTRL, CX3CL1, CYLD, CYLD-AS1, DDX28, DOK4, DPEP2, DPEP2NB, DPEP3, DRC7, DUS2, DYNC1LI2, DYNC1LI2-DT, E2F4, EDC4, ELMO3, ENKD1, ESRP2, EXOC3L1, FBXL8, FHOD1, FRA16B, FTO, FTO-IT1, GFOD2, GINS3, GNAO1, GNAO1-AS1, GNAO1-DT, GOT2, HEATR3, HERPUD1, HNRNPA1L3, HSD11B2, HSF4, IRX3, IRX5, IRX6, KATNB1, KCTD19, KIFC3, LCAT, LINC00919, LINC00920, LINC00922, LINC01571, LINC02126, LINC02127, LINC02128, LINC02137, LINC02140, LINC02141, LINC02168, LINC02169, LINC02178, LINC02180, LINC02911, LINC03064, LOC100505942, LOC101927272, LOC101927480, LOC102723373, LOC110120574, LOC110120575, LOC110120576, LOC110120577, LOC110120578, LOC110120579, LOC110120580, LOC110120581, LOC110120582, LOC110120583, LOC110120584, LOC110120585, LOC110120586, LOC110120587, LOC110120588, LOC110120835, LOC110120836, LOC110120837, LOC110120838, LOC110120839, LOC110120840, LOC110120841, LOC110120912, LOC110120939, LOC110121339, LOC110121356, LOC110121443, LOC112449715, LOC112449716, LOC112449717, LOC112469003, LOC112469004, LOC112469005, LOC112469006, LOC112469007, LOC112469008, LOC112469009, LOC112469010, LOC112469011, LOC112469012, LOC112469013, LOC112469014, LOC112469015, LOC112469016, LOC113939954, LOC121587545, LOC121587546, LOC121587547, LOC121587548, LOC121587549, LOC121587550, LOC121587551, LOC121847987, LOC121847988, LOC121847989, LOC125177305, LOC125177306, LOC125177307, LOC125177308, LOC125177309, LOC125177311, LOC125177312, LOC125177313, LOC125177314, LOC125177315, LOC125177316, LOC125177317, LOC125177318, LOC125177319, LOC125177320, LOC125177322, LOC125177323, LOC125177324, LOC125177325, LOC125177326, LOC125177327, LOC125177328, LOC125177330, LOC125177332, LOC125177333, LOC125177334, LOC125177336, LOC125177337, LOC125177338, LOC125177339, LOC125177340, LOC125177341, LOC125177342, LOC126862342, LOC126862343, LOC126862344, LOC126862345, LOC126862346, LOC126862347, LOC126862348, LOC126862349, LOC126862350, LOC126862351, LOC126862352, LOC126862353, LOC126862354, LOC126862355, LOC126862356, LOC126862357, LOC126862358, LOC126862359, LOC126862360, LOC126862361, LOC126862362, LOC126862363, LOC126862364, LOC126862365, LOC126862366, LOC126862367, LOC126862368, LOC126862369, LOC126862370, LOC126862371, LOC126862372, LOC126862373, LOC126862374, LOC126862375, LOC126862376, LOC126862377, LOC126862378, LOC126862379, LOC126862380, LOC126862381, LOC388282, LPCAT2, LRRC29, LRRC36, MATCAP1, MIR138-2, MIR3181, MIR328, MIR3935, MIR6771, MIR6772, MIR6773, MIR6863, MMP15, MMP2, MMP2-AS1, MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, MT2A, MT3, MT4, NAE1, NDRG4, NFATC3, NKD1, NLRC5, NOD2, NOL3, NRN1L, NUDT21, NUP93, NUP93-DT, NUTF2, OGFOD1, PARD6A, PDP2, PHAF1, PLA2G15, PLEKHG4, PLLP, POLR2C, PRMT7, PRSS54, PSKH1, PSMB10, PSME3IP1, RANBP10, RBL2, RIPOR1, RPGRIP1L, RRAD, RSPRY1, SALL1, SETD6, SLC12A3, SLC12A4, SLC38A7, SLC6A2, SLC7A6, SLC7A6OS, SLC9A5, SMPD3, SNORA46, SNORA50A, SNX20, TENT4B, TEPP, TERB1, THAP11, TK2, TMEM208, TOX3, TPPP3, TRADD, TRL-CAG2-1, TRL-CAG2-2, TSNAXIP1, USB1, ZDHHC1, ZNF319, ZNF423
See casesPathogenic
(Mar 18, 2014)
no assertion criteria provided
11.
GRCh37:
Chr16:49774718-51910531
GRCh38:
Chr16:49740807-51876620
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
12.
GRCh37:
Chr16:50818240-55600627
GRCh38:
Chr16:50784329-55566715
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
13.
GRCh37:
Chr16:51169910-51169911
GRCh38:
Chr16:51135999-51136000
SALL1Townes-Brocks syndrome 1Likely benign
(Jun 14, 2016)
criteria provided, single submitter
14.
GRCh37:
Chr16:51169989-51169990
GRCh38:
Chr16:51136078-51136079
SALL1Townes-Brocks syndrome 1Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
15.
GRCh37:
Chr16:51170095-51170097
GRCh38:
Chr16:51136184-51136186
SALL1not provided, Townes-Brocks syndrome 1Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
16.
GRCh37:
Chr16:51170317-51170318
GRCh38:
Chr16:51136406-51136407
SALL1Townes-Brocks syndrome 1Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
17.
GRCh37:
Chr16:51170435
GRCh38:
Chr16:51136524
SALL1Townes-Brocks syndrome 1Benign
(Jun 14, 2016)
criteria provided, single submitter
18.
GRCh37:
Chr16:51170460
GRCh38:
Chr16:51136549
SALL1Townes-Brocks syndrome 1Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
19.
GRCh37:
Chr16:51170930-51170931
GRCh38:
Chr16:51137019-51137020
SALL1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
20.
GRCh37:
Chr16:51170931-51170935
GRCh38:
Chr16:51137020-51137024
SALL1Townes-Brocks syndrome 1, not providedLikely benign
(Mar 31, 2019)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr16:51171034
GRCh38:
Chr16:51137123
SALL1V1225I, V1322Inot provided, Townes syndrome, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Nov 7, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr16:51171035
GRCh38:
Chr16:51137124
SALL1I1224M, I1321Mnot providedBenign
(Oct 14, 2020)
criteria provided, single submitter
23.
GRCh37:
Chr16:51171041
GRCh38:
Chr16:51137130
SALL1not provided, Townes syndromeLikely benign
(Jul 14, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr16:51171051
GRCh38:
Chr16:51137140
SALL1E1316G, E1219GInborn genetic diseasesUncertain significance
(Oct 6, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr16:51171056
GRCh38:
Chr16:51137145
SALL1not provided, not specified, Townes-Brocks syndrome 1,
Townes syndrome
Benign/Likely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr16:51171060
GRCh38:
Chr16:51137149
SALL1R1313H, R1216HInborn genetic diseases, Townes syndrome, not provided
Conflicting interpretations of pathogenicity
(Jul 12, 2022)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr16:51171061
GRCh38:
Chr16:51137150
SALL1R1313C, R1216CTownes syndromeUncertain significance
(Jun 4, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr16:51171083
GRCh38:
Chr16:51137172
SALL1Townes syndrome, not specified, not provided
Benign
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr16:51171108
GRCh38:
Chr16:51137197
SALL1L1297R, L1200RTownes syndrome, Inborn genetic diseasesUncertain significance
(Nov 8, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr16:51171126
GRCh38:
Chr16:51137215
SALL1N1291S, N1194STownes syndrome, not specified, not provided,
Townes-Brocks syndrome 1
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr16:51171151
GRCh38:
Chr16:51137240
SALL1E1186K, E1283KTownes-Brocks syndrome 1Uncertain significance
(Mar 31, 2020)
criteria provided, single submitter
32.
GRCh37:
Chr16:51171155
GRCh38:
Chr16:51137244
SALL1N1184K, N1281KTownes syndromeUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr16:51171162
GRCh38:
Chr16:51137251
SALL1T1182M, T1279MInborn genetic diseases, Townes syndrome, not provided
Uncertain significance
(Mar 4, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr16:51171175
GRCh38:
Chr16:51137264
SALL1V1275I, V1178Inot provided, not specified, Townes syndrome,
Townes-Brocks syndrome 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr16:51171190
GRCh38:
Chr16:51137279
SALL1G1173R, G1270Rnot specifiedUncertain significance
(Feb 11, 2020)
criteria provided, single submitter
36.
GRCh37:
Chr16:51171197
GRCh38:
Chr16:51137286
SALL1Townes syndromeLikely benign
(Apr 8, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr16:51171204
GRCh38:
Chr16:51137293
SALL1G1265E, G1168ETownes syndrome, not specified, not provided,
Townes-Brocks syndrome 1
Benign/Likely benign
(Sep 17, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr16:51171211
GRCh38:
Chr16:51137300
SALL1I1166V, I1263VTownes-Brocks syndrome 1Uncertain significance
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr16:51171216
GRCh38:
Chr16:51137305
SALL1P1164R, P1261RTownes-Brocks syndrome 1, not providedUncertain significance
(Dec 6, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr16:51171216
GRCh38:
Chr16:51137305
SALL1P1164L, P1261LTownes-Brocks syndrome 1Uncertain significance
(Aug 26, 2020)
criteria provided, single submitter
41.
GRCh37:
Chr16:51171217
GRCh38:
Chr16:51137306
SALL1P1164S, P1261SInborn genetic diseasesUncertain significance
(Oct 21, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr16:51171227
GRCh38:
Chr16:51137316
SALL1not specified, Townes syndrome, Townes-Brocks syndrome 1
Likely benign
(Feb 7, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr16:51171239
GRCh38:
Chr16:51137328
SALL1Townes syndrome, not providedLikely benign
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr16:51171248
GRCh38:
Chr16:51137337
SALL1not provided, Townes syndromeConflicting interpretations of pathogenicity
(Aug 6, 2022)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr16:51171261
GRCh38:
Chr16:51137350
SALL1A1149V, A1246VInborn genetic diseasesUncertain significance
(Jul 6, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr16:51171269
GRCh38:
Chr16:51137358
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr16:51171270
GRCh38:
Chr16:51137359
SALL1N1146S, N1243STownes-Brocks syndrome 1, Townes syndromeUncertain significance
(May 6, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr16:51171278
GRCh38:
Chr16:51137367
SALL1Townes syndromeLikely benign
(Aug 28, 2019)
criteria provided, single submitter
49.
GRCh37:
Chr16:51171302
GRCh38:
Chr16:51137391
SALL1S1232R, S1135RInborn genetic diseasesUncertain significance
(Jul 26, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr16:51171313
GRCh38:
Chr16:51137402
SALL1D1132N, D1229Nnot provided, Inborn genetic diseasesUncertain significance
(Feb 22, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr16:51171332
GRCh38:
Chr16:51137421
SALL1Townes syndromeLikely benign
(Sep 10, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr16:51171333
GRCh38:
Chr16:51137422
SALL1A1125V, A1222VTownes syndrome, not providedBenign/Likely benign
(Sep 8, 2021)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr16:51171367
GRCh38:
Chr16:51137456
SALL1V1114F, V1211FTownes-Brocks syndrome 1, not providedUncertain significance
(Nov 17, 2021)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr16:51171368
GRCh38:
Chr16:51137457
SALL1Townes syndromeLikely benign
(Apr 7, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr16:51171375
GRCh38:
Chr16:51137464
SALL1G1111D, G1208Dnot providedUncertain significance
(Jul 22, 2019)
criteria provided, single submitter
56.
GRCh37:
Chr16:51171395
GRCh38:
Chr16:51137484
SALL1not providedBenign
(Jun 4, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr16:51171397
GRCh38:
Chr16:51137486
SALL1G1201S, G1104Snot providedUncertain significance
(Aug 8, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr16:51171414
GRCh38:
Chr16:51137503
SALL1R1195Q, R1098QTownes syndromeUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
59.
GRCh37:
Chr16:51171461
GRCh38:
Chr16:51137550
SALL1Townes syndromeLikely benign
(Jun 14, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr16:51171494-51171495
GRCh38:
Chr16:51137583-51137584
SALL1not provided, not specifiedBenign/Likely benign
(Aug 11, 2019)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr16:51171615
GRCh38:
Chr16:51137704
SALL1not providedLikely benign
(Nov 16, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr16:51171670
GRCh38:
Chr16:51137759
SALL1not providedBenign
(Jun 19, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr16:51172325
GRCh38:
Chr16:51138414
SALL1not providedBenign
(Jun 28, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr16:51172559
GRCh38:
Chr16:51138648
SALL1not providedBenign
(Dec 9, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr16:51172594
GRCh38:
Chr16:51138683
SALL1not specifiedLikely benign
(Jan 4, 2017)
criteria provided, single submitter
66.
GRCh37:
Chr16:51172677
GRCh38:
Chr16:51138766
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1,
not specified
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr16:51172696
GRCh38:
Chr16:51138785
SALL1S1049L, S1146LTownes syndromeUncertain significance
(Feb 4, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr16:51172718-51172719
GRCh38:
Chr16:51138807-51138808
SALL1C1042fs, C1139fsnot provided, Townes-Brocks syndrome 1, Townes syndrome
Pathogenic
(Jul 17, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr16:51172724
GRCh38:
Chr16:51138813
SALL1N1040D, N1137DTownes syndromeUncertain significance
(Oct 14, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr16:51172752
GRCh38:
Chr16:51138841
SALL1R1031fs, R1128fsTownes-Brocks syndrome 1Likely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr16:51172753
GRCh38:
Chr16:51138842
SALL1P1030L, P1127Lnot providedBenign
(May 3, 2019)
criteria provided, single submitter
72.
GRCh37:
Chr16:51172786
GRCh38:
Chr16:51138875
SALL1S1019F, S1116FTownes syndromeUncertain significance
(Apr 4, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr16:51172803
GRCh38:
Chr16:51138892
SALL1not provided, Townes-Brocks syndrome 1Likely benign
(Dec 23, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr16:51172806
GRCh38:
Chr16:51138895
SALL1Townes syndromeLikely benign
(Dec 21, 2020)
criteria provided, single submitter
75.
GRCh37:
Chr16:51172807
GRCh38:
Chr16:51138896
SALL1P1109L, P1012Lnot providedLikely pathogenic
(Mar 31, 2017)
criteria provided, single submitter
76.
GRCh37:
Chr16:51172811
GRCh38:
Chr16:51138900
SALL1V1011F, V1108FTownes-Brocks syndrome 1Uncertain significance
(May 21, 2020)
criteria provided, single submitter
77.
GRCh37:
Chr16:51172811
GRCh38:
Chr16:51138900
SALL1V1011L, V1108Lnot provided, Townes syndromeBenign/Likely benign
(Jan 2, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr16:51172811
GRCh38:
Chr16:51138900
SALL1V1011I, V1108Inot specified, Townes-Brocks syndrome 1Likely benign
(Dec 29, 2021)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr16:51172823
GRCh38:
Chr16:51138912
SALL1P1007A, P1104ATownes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr16:51172828
GRCh38:
Chr16:51138917
SALL1D1102G, D1005Gnot providedUncertain significance
(May 17, 2016)
criteria provided, single submitter
81.
GRCh37:
Chr16:51172863
GRCh38:
Chr16:51138952
SALL1Townes syndrome, not providedConflicting interpretations of pathogenicity
(Jul 12, 2022)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr16:51172891
GRCh38:
Chr16:51138980
SALL1L1081S, L984Snot providedLikely benign
(Dec 23, 2019)
criteria provided, single submitter
83.
GRCh37:
Chr16:51172902
GRCh38:
Chr16:51138991
SALL1Townes syndrome, Townes-Brocks syndrome 1Likely benign
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr16:51172911
GRCh38:
Chr16:51139000
SALL1not providedUncertain significance
(Aug 18, 2017)
criteria provided, single submitter
85.
GRCh37:
Chr16:51172911
GRCh38:
Chr16:51139000
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr16:51172934
GRCh38:
Chr16:51139023
SALL1L1067F, L970FTownes-Brocks syndrome 1, Townes syndromeConflicting interpretations of pathogenicity
(Jul 6, 2022)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr16:51172953
GRCh38:
Chr16:51139042
SALL1Townes syndromeLikely benign
(Mar 2, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr16:51172953
GRCh38:
Chr16:51139042
SALL1Townes syndrome, not specified, not provided,
Townes-Brocks syndrome 1
Benign/Likely benign
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr16:51172960
GRCh38:
Chr16:51139049
SALL1S1058C, S961Cnot providedUncertain significance
(Jul 29, 2020)
criteria provided, single submitter
90.
GRCh37:
Chr16:51172973
GRCh38:
Chr16:51139062
SALL1R1054*, R957*Townes syndrome, not providedPathogenic/Likely pathogenic
(Nov 7, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr16:51172976
GRCh38:
Chr16:51139065
SALL1M1053L, M956Lnot providedUncertain significance
(Aug 5, 2016)
criteria provided, single submitter
92.
GRCh37:
Chr16:51172979
GRCh38:
Chr16:51139068
SALL1Q1052*, Q955*not providedLikely pathogenic
(Aug 5, 2016)
criteria provided, single submitter
93.
GRCh37:
Chr16:51173013
GRCh38:
Chr16:51139102
SALL1not specified, not provided, Townes syndrome,
Townes-Brocks syndrome 1
Benign/Likely benign
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr16:51173027-51173028
GRCh38:
Chr16:51139116-51139117
SALL1R1036fs, R939fsnot providedPathogenic
(Sep 22, 2016)
criteria provided, single submitter
95.
GRCh37:
Chr16:51173038
GRCh38:
Chr16:51139127
SALL1T1032I, T935ITownes syndromeUncertain significance
(Aug 31, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr16:51173045
GRCh38:
Chr16:51139134
SALL1I1030V, I933VTownes syndrome, Townes-Brocks syndrome 1Uncertain significance
(Jan 3, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr16:51173049
GRCh38:
Chr16:51139138
SALL1not provided, Townes-Brocks syndrome 1Likely benign
(Aug 16, 2021)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr16:51173065
GRCh38:
Chr16:51139154
SALL1H1023P, H926Pnot providedUncertain significance
(Apr 17, 2020)
criteria provided, single submitter
99.
GRCh37:
Chr16:51173112
GRCh38:
Chr16:51139201
SALL1not providedUncertain significance
(Dec 5, 2016)
criteria provided, single submitter
100.
GRCh37:
Chr16:51173125-51173128
GRCh38:
Chr16:51139214-51139217
SALL1A1002fs, A905fsTownes syndromePathogenic
(Oct 23, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination